MPE beim mutierten NSCLC: Intrapleurale Applikation von Bevacizumab stellt effektive Therapie dar
Year: 2024
Type: article
Study design: Observational Study
Source: Kompass Onkologie
DOI: 10.1159/000540909
Author: Dr. Franz Stanzel
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4401738601
